Journal Guide

Pharmacien Hospitalier et Clinicien promotes optimal pharmaceutical care, safer uses of medicines and medical devices, assess therapeutics and improves patient safety goals. Partnering the French Society of Clinical Pharmacy, Center for Information on Therapeutic Agents, National Association of Clinical Pharmacy Teachers, it publishes recent research reports, synthetic and critical reviews, and didactical articles on all fields of health-system pharmacy (pharmacotherapy, medical devices use, drug compounding, compliance, dosage, posology and route of use, pharmacy education, family medicine, information technology, drug security and quality of patient care). It encourages publication and rewards the work of young authors, with special attention to those from French-speaking, emerging countries.La revue Le pharmacien hospitalier et Clinicien a obtenu l'agrément du Haut Comité à la Formation Pharmaceutique Continue.- PHC est l'un des moyens d'expression de la SFPC, de L'ANEPC et du CNHIM reconnu comme l'un des piliers de la formation continue en matière de Pharmacie des Etablissements de santé et des Collectivités, de Pharmacie Clinique et de Pharmacie Universitaire et d'évaluation.- PHC regroupe tous les domaines de la pharmacie hospitalière, dont : stérilisation, pharmacie clinique, techniques de l'information et automatisation, management.- L'objectif de PHC est d'aider nos confrères à Découvrir, Savoir, Eduquer, Prendre soin et Améliorer la Santé- La politique rédactionnelle de PHC : intégrer dans la pratique quotidienne des pharmaciens l'essentiel des progrès scientifiques et techniques, privilégier le dialogue avec les cliniciens prescripteurs et les patients. Les domaines représentés sont principalement : Pharmacie des Etablissements de Santé, Pharmacie clinique, Pharmacothérapie, Pharmacotechnie, Santé publique, économie de la santé.

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Communication. Particular areas of interest include:

Pharmacology & Therapeutics presents lucid, critical and authoritative reviews of currently important topics in pharmacology. Since articles are commissioned, instructions to authors are provided by the editor responsible for recruiting the work. Celebrating its 20th year of scientific excellence, Pharmacology & Therapeutics continues to be among the top 10 most cited journals in pharmacology.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Covering all new advances in psychotropic drugs, Pharmacopsychiatry provides psychiatrists and pharmacologists with key clinical insights and information about new avenues of research and treatment. The pharmacological, neurophysiological, and psychological basis of psychiatric disorders are explored using models and model theory as applied to clinical and experimental studies.Pharmacopsychiatry publishes information about controlled clinical trials, case reports, and meeting proceedings, and serves as a state-of-the-art tool for advancing the field and setting European standards.*Psychiatry/Gerontopsychiatry*Pharmacology/Clinical Pharmacology*Neuro and Psychophysiology*Psychology and Neurobiology.

Pharmacotherapy is devoted to original research articles on all aspects of human pharmacology and review articles on drug therapy. The editors and editorial board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.

Official Journal of the European Platform for Photodynamic Medicine Affiliated with the International Photodynamic AssociationAlso affiliated with the British Medical Laser Associationand the Polish Society for Photodynamic MedicineFIRST IMPACT FACTOR (2010): 2.302NOW INDEXED in SciSearch/Science Citation Index Expanded, Current Contents/Clinical Medicine.NOW INCLUDED in MEDLINE/PubMed.Aims and Scope:Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.Electronic usage:An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.Average monthly article downloads for this journal: 3,962** Figure is a monthly average of full-text articles downloaded from ScienceDirect between October 2012 and October 2013

Primary Care: Clinics in Office Practice updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each quarterly issue (March, June, September, and December) focuses on a single topic in primary care. Topics covered include allergy and immunology, cardiology, adolescent health, endocrinology, ENT, gastroenterology, geriatrics, hematology/oncology, infectious disease, gynecology and women's health, nephrology, neurology, orthopedics/sports medicine, pediatrics, preventive medicine, psychiatry, rheumatology, and urology.

Bring the most current psychopharmacologic and therapeutic neuromodulation interventions to the expert management of your practice. Psychopharm Review offers the most essential, practical advice for recognizing and treating virtually all types of psychiatric disorders. With Psychopharm Review you will:Make well-informed decisions to address neurocognitive effects of medications in elderly patients, treatment of bipolar disorder, and the hazards of inappropriately prescribed medications.Stay current on neuromodulation therapies such as vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), and deep brain stimulation (DBS).Fully understand the key issues that can affect your patients' mental health, how to achieve more consistent treatment adherence, and how to approach ethical issues surrounding various therapies.Receive critical reviews of groundbreaking medication trials, such as CATIE and STAR*D.Psychopharm Review understands the demands of daily practice and provides you with practical treatment strategies.

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung• Physiology• Pathology• Drug delivery• Metabolism• Pulmonary ToxicologyBefore submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.Immediate rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controlsImmediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).4. Inappropriate experiments or lacking essential detailImmediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time5. Lack of novelty: The study must represent a novel approach to the field.Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the fieldNote that only manuscripts written in good English will be considered by the Editors (British usage is preferred).

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery.